The maker of Ozempic is cutting the price of the drug nearly in half for some patients. Novo Nordisk had already cut the price of Wegovy, a medication with the same active ingredient that's approved for weight loss.

The weight loss injectable Ozempic has faced several lawsuits in 2025 from people who had a negative experience with the semaglutide.

Fact checked by Nick Blackmer With anti-obesity medications like Ozempic, Wegovy, and Zepbound exploding in popularity in recent years, there’s no shortage of chatter about surprising side effects, such as “Ozempic face” and “Ozempic butt.

Price hikes are 'kick in the teeth' for patients who will either have to swallow 170 per cent price increase, or switch to 'almost as good' competitor

A new study in mice has found that muscle loss associated with weight loss from GLP-1 medications like Ozempic may not be as high as recently thought.

Just like when you find a glitzy resort in your dream destination, your first question about weight loss drugs might be, how much is this going to set me back? Lucky for you, we’ve done our homework.

Stopping prescription weight loss drugs often leads to significant weight regain, according to a large-scale analysis of 11 global studies. Researchers found that although these medications, including GLP-1-based treatments like semaglutide and tirzepatide,

Past research has found that Ozempic may have more health beyond weight loss and weight management. Now, three new studies suggest that GLP-1s could help prevent and treat stroke, and experts say the connection makes sense. If you don't want to take medication, there are other ways to reduce your risk of stroke through lifestyle changes.

Ozempic and other GLP-1 drugs have become extremely popular for their ability to manage Type 2 diabetes symptoms and spur weight loss. A recent study found that about 4% of Americans took these meds last year.